On the basis of the above analysis of pathway correlation and core targets, we mainly focused on the anti-inflammatory mechanism of QZZD in treating AD and assembled it into a synthetic pathway (Figure 7) with TNF signaling pathway as the main pathway, including Aβ-associated signaling pathway, NF-kappaB signaling pathway and PI3K-Akt signaling pathway. This evidence concerns the gene AKT1 and Alzheimer disease.